Blog Category

Regulatory

BIOPHYTIS ANNOUNCES APPROVAL OF THE OBA CLINICAL TRIAL IN BRAZIL AND SHARES ITS OUTLOOK FOR BIO101 IN OBESITY

, ,

/

10 August 2026

Biophytis announces the auditing of its 2025 financial statements and the resumption of trading in its stock

, , ,

/

29 July 2026

SEPTEMBER 3, 2025

,

/

3 September 2025

AUGUST 28, 2025

,

/

28 August 2025

July 11, 2024

, , ,

/

11 July 2024

JUNE 10, 2024

,

/

10 June 2024

SEPTEMBER 11, 2023

,

/

11 September 2023

AUGUST 8, 2023

,

/

8 August 2023

JULY 20, 2023

,

/

20 July 2023

MAY 26, 2023

,

/

26 May 2023

MAY 15, 2023

,

/

15 May 2023

MAY 9, 2023

,

/

9 May 2023